2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
LaRovere KL, Riggs BJ, Poussaint TY, Young CC, Newhams MM, Maamari M, Walker TC, Singh AR, Dapul H, Hobbs CV, McLaughlin GE, Son MBF, Maddux AB, Clouser KN, Rowan CM, McGuire JK, Fitzgerald JC, Gertz SJ, Shein SL, Munoz AC, Thomas NJ, Irby K, Levy ER, Staat MA, Tenforde MW, Feldstein LR, Halasa NB, Giuliano JS, Hall MW, Kong M, Carroll CL, Schuster JE, Doymaz S, Loftis LL, Tarquinio KM, Babbitt CJ, Nofziger RA, Kleinman LC, Keenaghan MA, Cvijanovich NZ, Spinella PC, Hume JR, Wellnitz K, Mack EH, Michelson KN, Flori HR, Patel MM, Randolph AG, Last Name* F, Gaspers M, Typpo K, Sanders R, Schwarz A, Harvey H, Zinter M, Mourani P, Coates B, Bhoojhawon G, Havlin K, Montgomery V, Sullivan J, Bradford T, Bembea M, Lipton S, Graciano A, Chen S, Kucukak S, Newburger J, Carroll R, Fernandes N, Yager P, Marohn K, Heidemann S, Cullimore M, McCulloh R, Horwitz S, Li S, Walsh R, Ratner A, Soma V, Gillen J, Zackai S, Ackerman K, Cholette J, Harwayne-Gidansky I, Hymes S, Overby P, Schwartz S, Lansell A, Koncicki M, Carcillo J, Fink E, Kimura D, Bowens C, Crandall H, Smith L, Cengiz P. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome. JAMA Neurology 2021, 78: 536-547. PMID: 33666649, PMCID: PMC7936352, DOI: 10.1001/jamaneurol.2021.0504.Peer-Reviewed Original ResearchConceptsMultisystem inflammatory syndromeNeurologic involvementInflammatory syndromeLife-threatening conditionHospital dischargeTransient symptomsNeurologic conditionsPositive severe acute respiratory syndrome coronavirus 2 test resultCOVID-19Severe acute respiratory syndrome coronavirus 2Life-threatening neurologic conditionAcute respiratory syndrome coronavirus 2Long-term neurodevelopmental outcomesRespiratory syndrome coronavirus 2Fatal neurologic conditionFulminant cerebral edemaLife-threatening involvementNew neurologic deficitsAcute neurologic signsSyndrome coronavirus 2Coronavirus disease 2019Public health registriesFibrinogen equivalent unitsAdult patientsCerebral edema
2020
Risk of COVID-19 infection after cardiac electrophysiology procedures
Workman V, Freeman JV, Obasare ER, Jain S, Ganeshan R, Burr A, Blitzer M, Akar J, Lampert R. Risk of COVID-19 infection after cardiac electrophysiology procedures. Heart Rhythm O2 2020, 1: 239-242. PMID: 32904452, PMCID: PMC7455246, DOI: 10.1016/j.hroo.2020.08.006.Peer-Reviewed Original ResearchCOVID-19 infectionEP proceduresNosocomial spreadCOVID-19Probable COVID-19 infectionMedical record reviewPreventive measuresCOVID-19 patientsRisk of developmentCOVID-19 surgeChest painHospital stayHospital transmissionRecord reviewTransient symptomsEmergent proceduresCardiac electrophysiology proceduresNonemergent proceduresElectrophysiology labElectrophysiology proceduresEP labPatientsHospital censusCoronavirus infectionSymptoms
2011
Prediction of Early Stroke Risk in Transient Symptoms With Infarction
Arsava E, Furie K, Schwamm L, Sorensen A, Ay H. Prediction of Early Stroke Risk in Transient Symptoms With Infarction. Stroke 2011, 42: 2186-2190. PMID: 21680907, PMCID: PMC3144273, DOI: 10.1161/strokeaha.110.604280.Peer-Reviewed Original ResearchConceptsTransient ischemic attackReceiver-operating characteristic curveIschemic attackStroke riskTransient symptomsDiffusion-weighted imagesStroke prevention strategiesHigh-risk patientsRisk of strokeEarly stroke riskCharacteristic curveNew infarctionRecurrent strokeClinical deteriorationConsecutive patientsIschemic strokeSymptom onsetIndex lesionRetrospective seriesPrevention strategiesPatientsEarly interventionInfarctionStrokeSubsequent stroke
2009
Cerebral Ischemic Events Associated With ‘Bubble Study’ for Identification of Right to Left Shunts
Romero J, Frey J, Schwamm L, Demaerschalk B, Chaliki H, Parikh G, Burke R, Babikian V. Cerebral Ischemic Events Associated With ‘Bubble Study’ for Identification of Right to Left Shunts. Stroke 2009, 40: 2343-2348. PMID: 19498192, DOI: 10.1161/strokeaha.109.549683.Peer-Reviewed Original ResearchConceptsCerebral ischemic eventsIschemic eventsPatent foramenBubble studyIschemic strokePulmonary shuntEarly brain MRIIschemic Cerebrovascular ComplicationsCryptogenic ischemic strokeTransient ischemic attackEvaluation of patientsPulmonary arteriovenous malformationsDegree of disabilitySaline intravenous injectionCerebrovascular complicationsIschemic attackInfarct volumeIschemic complicationsRare complicationAcute infarctionClinical featuresTransient symptomsTrue incidenceReporting of drugDevice complications
2006
Transient ischemic attack with infarction: A unique syndrome?
Ay H, Koroshetz W, Benner T, Vangel M, Wu O, Schwamm L, Sorensen A. Transient ischemic attack with infarction: A unique syndrome? International Congress Series 2006, 1290: 45-55. DOI: 10.1016/j.ics.2006.04.007.Peer-Reviewed Original ResearchTransient ischemic attackIschemic strokeIschemic attackSymptom durationDistinct prognostic featuresSeparate clinical syndromesRecurrent ischemic strokeMinor ischemic strokeUnderwent diffusion-weighted imagingDiffusion-weighted imagingInfarct volumeConsecutive patientsTIA ratePrognostic featuresTransient symptomsBrain syndromeClinical syndromeUnique syndromeInfarctionPatientsStrokeSyndromeSymptomsDurationInfarcts
2005
Transient ischemic attack with infarction: A unique syndrome?
Ay H, Koroshetz W, Benner T, Vangel M, Wu O, Schwamm L, Sorensen A. Transient ischemic attack with infarction: A unique syndrome? Annals Of Neurology 2005, 57: 679-686. PMID: 15852402, DOI: 10.1002/ana.20465.Peer-Reviewed Original ResearchConceptsTransient ischemic attackIschemic strokeIschemic attackSymptom durationDistinct prognostic featuresSeparate clinical syndromesRecurrent ischemic strokeMinor ischemic strokeUnderwent diffusion-weighted imagingDiffusion-weighted imagingInfarct volumeConsecutive patientsTIA ratePrognostic featuresTransient symptomsBrain syndromeClinical syndromeUnique syndromeInfarctionPatientsStrokeSyndromeSymptomsDurationInfarcts
2004
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH. The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. Neuropsychopharmacology 2004, 29: 1558-1572. PMID: 15173844, DOI: 10.1038/sj.npp.1300496.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnxietyArousalAttentionBehaviorCognitionDose-Response Relationship, DrugDouble-Blind MethodDronabinolFemaleHallucinogensHemodynamicsHumansHydrocortisoneInjections, IntravenousMaleMemory, Short-TermMental RecallPanicProlactinPsychiatric Status Rating ScalesPsychometricsPsychoses, Substance-InducedSpeechVerbal LearningConceptsCannabinoid receptor functionWord recallRecognition recallVerbal fluencyCognitive deficitsProspective safety dataNegative symptomsAbuse disordersHealthy individualsCounterbalanced studyMonths poststudyRecallPsychotomimetic effectsPsychotic disordersReceptor functionPsychosisEndogenous psychosesIndividualsDistractibilityFluencyTransient symptomsDisordersEndocrine effectsSafety dataAnxiety
2003
Toward early pharmacological posttraumatic stress intervention
Morgan CA, Krystal JH, Southwick SM. Toward early pharmacological posttraumatic stress intervention. Biological Psychiatry 2003, 53: 834-843. PMID: 12725976, DOI: 10.1016/s0006-3223(03)00116-1.Peer-Reviewed Original ResearchConceptsPosttraumatic stress disorderExtreme psychological traumaStress-related symptomsIntrusive memoriesPsychological processingExtreme arousalTrauma survivorsPsychological traumaStress disorderStress interventionsAcute aftermathExtreme stressPharmacologic interventionsAdaptive roleEffective pharmacologic interventionsPotential pharmacologic interventionsInterventionTransient symptomsImmediate aftermathArousalEmpirical dataEarly symptomsMemorySymptomsTrauma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply